Senestech, Inc. (NASDAQ:SNES – Get Free Report) major shareholder Glenbrook Capital Management bought 7,120 shares of the business’s stock in a transaction dated Friday, May 15th. The stock was acquired at an average price of $1.65 per share, for a total transaction of $11,748.00. Following the purchase, the insider directly owned 915,755 shares in the company, valued at approximately $1,510,995.75. The trade was a 0.78% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. Large shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.
Glenbrook Capital Management also recently made the following trade(s):
- On Monday, May 18th, Glenbrook Capital Management bought 10,000 shares of Senestech stock. The stock was acquired at an average price of $1.59 per share, for a total transaction of $15,900.00.
- On Thursday, May 14th, Glenbrook Capital Management bought 15,000 shares of Senestech stock. The stock was acquired at an average price of $1.72 per share, for a total transaction of $25,800.00.
- On Tuesday, April 28th, Glenbrook Capital Management bought 3,000 shares of Senestech stock. The stock was acquired at an average price of $1.47 per share, for a total transaction of $4,410.00.
- On Tuesday, March 17th, Glenbrook Capital Management bought 19,725 shares of Senestech stock. The stock was acquired at an average price of $1.79 per share, for a total transaction of $35,307.75.
- On Monday, March 16th, Glenbrook Capital Management bought 5,060 shares of Senestech stock. The stock was acquired at an average price of $1.86 per share, for a total transaction of $9,411.60.
- On Friday, March 13th, Glenbrook Capital Management purchased 146,249 shares of Senestech stock. The stock was bought at an average cost of $1.95 per share, for a total transaction of $285,185.55.
- On Thursday, February 19th, Glenbrook Capital Management purchased 34,613 shares of Senestech stock. The stock was bought at an average cost of $2.40 per share, for a total transaction of $83,071.20.
- On Wednesday, February 18th, Glenbrook Capital Management purchased 10,481 shares of Senestech stock. The stock was bought at an average cost of $2.29 per share, for a total transaction of $24,001.49.
- On Tuesday, February 17th, Glenbrook Capital Management purchased 40,807 shares of Senestech stock. The stock was bought at an average cost of $2.29 per share, for a total transaction of $93,448.03.
Senestech Trading Down 1.9%
NASDAQ:SNES opened at $1.59 on Tuesday. The company has a current ratio of 8.91, a quick ratio of 7.79 and a debt-to-equity ratio of 0.02. The stock has a market capitalization of $8.43 million, a PE ratio of -0.84 and a beta of 0.18. The firm’s 50 day moving average is $1.70 and its 200 day moving average is $2.16. Senestech, Inc. has a 12 month low of $1.41 and a 12 month high of $6.24.
Institutional Investors Weigh In On Senestech
Hedge funds and other institutional investors have recently bought and sold shares of the business. Renaissance Technologies LLC raised its holdings in Senestech by 35.2% during the 4th quarter. Renaissance Technologies LLC now owns 142,800 shares of the company’s stock valued at $306,000 after acquiring an additional 37,165 shares during the period. DRW Securities LLC raised its holdings in Senestech by 171.1% during the 4th quarter. DRW Securities LLC now owns 82,107 shares of the company’s stock valued at $176,000 after acquiring an additional 51,818 shares during the period. Jane Street Group LLC bought a new stake in Senestech during the 2nd quarter valued at $161,000. Millennium Management LLC bought a new stake in Senestech during the 3rd quarter valued at $126,000. Finally, Geode Capital Management LLC bought a new stake in Senestech during the 2nd quarter valued at $59,000. Institutional investors own 5.19% of the company’s stock.
Analysts Set New Price Targets
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Senestech in a report on Friday, March 27th. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold”.
View Our Latest Research Report on Senestech
About Senestech
SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.
The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.
See Also
- Five stocks we like better than Senestech
- Why Applied Optoelectronics Stock May Be Near a Turning Point
- From High-Yield to High-Growth: 3 Stocks Boosting Dividends
- Is Everspin Technologies the Next AI Edge Breakout?
- 5 Robotics Stocks to Watch as Physical AI Builds Momentum
Receive News & Ratings for Senestech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senestech and related companies with MarketBeat.com's FREE daily email newsletter.
